.Actinogen Medical's cortisol blocker has missed the main endpoint of a phase 2 research study in cl...
.Antibody-drug conjugates (ADCs) have actually gone to the facility of several a billion-dollar biob...
.Property manager TPG, which has sustained biotechs like Sionna Therapies as well as Santa Ana Biogr...
.Merck & Co.'s TIGIT program has actually gone through an additional drawback. Months after shutt...
.After a year specified by pipeline cuts, the variation of its chief executive officer and discharge...
.Cullinan Therapeutics was made an impression on sufficient with Port BioMed's bispecific immune act...
.In this week's incident of "The Leading Pipe," our experts are actually diving in to Fierce Biotech...
.The confetti is still soaring coming from Eli Lilly's celebration commemorating the commendation of...
.Accept to this week's Chutes & Ladders, our summary of substantial management hirings, firings a...
.Complying with an inadequate showing for Lykos Therapies' MDMA candidate for trauma at a recent FDA...